These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1834080)

  • 1. [Cost-benefits of vaccination against hepatitis B in hospital personnel in Venezuela].
    Fernández Barboza R; Rivero D; Echeverría B; Machado IV
    Bol Oficina Sanit Panam; 1991 Jul; 111(1):16-23. PubMed ID: 1834080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
    Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients.
    Oddone EZ; Cowper PA; Hamilton JD; Feussner JR
    Health Serv Res; 1993 Apr; 28(1):97-121. PubMed ID: 8463111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simplified financial cost-effectiveness analysis of programs for prevention of hepatitis B accidental inoculation among hospital personnel in Thailand.
    Chongsuvivatwong V
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):189-93. PubMed ID: 2532789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection.
    Thomas DL; Factor SH; Kelen GD; Washington AS; Taylor E; Quinn TC
    Arch Intern Med; 1993 Jul; 153(14):1705-12. PubMed ID: 8333808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening and vaccination against hepatitis B among health personnel. Short-term results].
    Bertoglio C; Ariotti G; Demicheli V; Marino G; Piccinelli V; Leccardi E; Allosia GP; Corti E; Ballerini P
    Minerva Med; 1987 Apr; 78(8):537-42. PubMed ID: 2952903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A method for evaluating the hepatitis B vaccination program].
    Corrao G; Calleri M; Carle F; Russo R; Favilli S
    Ann Ist Super Sanita; 1989; 25(2):337-43. PubMed ID: 2531564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A cost-effectiveness analysis of vaccination against the hepatitis B virus].
    Antoñanzas F; Forcén T; Garuz R
    Med Clin (Barc); 1992 Jun; 99(2):41-6. PubMed ID: 1630178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B vaccination programs for health care personnel in U.S. hospitals.
    Alexander PG; Johnson R; Williams WW; Hadler SC; White JW; Coleman PJ
    Public Health Rep; 1990; 105(6):610-6. PubMed ID: 2148012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eradication of hepatitis B in Portugal. A challenge within reach of the National Health Service].
    Caetano JA
    Acta Med Port; 1990; 3(2):71-4. PubMed ID: 2140923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Forecasting strategies of hepatitis B vaccination based on decision tree model].
    Zhang SX
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):193-7. PubMed ID: 2509074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal hepatitis B vaccination: the economics of prevention.
    Krahn MD; Detsky AS
    CMAJ; 1992 Jan; 146(1):19-21. PubMed ID: 1530815
    [No Abstract]   [Full Text] [Related]  

  • 18. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against hepatitis B virus in workers of a general hospital in Athens.
    Rachiotis G; Goritsas C; Alikakou V; Ferti A; Roumeliotou A
    Med Lav; 2005; 96(1):80-6. PubMed ID: 15847111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current hepatitis B epidemiology in Germany].
    Kralj N; Hofmann F; Michaelis M; Berthold H
    Gesundheitswesen; 1998 Jul; 60(7):450-5. PubMed ID: 9738355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.